Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-infected Individuals”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002406
What this trial is testing

A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 350
Not applicableStudy completedNCT02639936
What this trial is testing

New Generation IGRA in Immunocompromised Individuals

Who this might be right for
Monitoring, ImmunologicActive TuberculosisTuberculosis in Solid Organ Transplant Recipients+4 more
Tuberculosis Network European Trialsgroup 2,663
Large-scale testing (Phase 3)Study completedNCT00160329
What this trial is testing

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia

Who this might be right for
HyperlipidemiaHIV Infections
Stanford University 60
Early research (Phase 1)Ended earlyNCT03831945
What this trial is testing

Combination Therapy With VRC01 and 10-1074 in HIV-Infected Individuals Undergoing Sequential Treatment Interruptions

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT01816490
What this trial is testing

THISTLE - The HIV-HCV Silibinin Trial

Who this might be right for
HIVHepatitis C
University of Zurich 20
Not applicableStudy completedNCT02906137
What this trial is testing

Gut-Associated Lymphocyte Trafficking

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 80
Large-scale testing (Phase 3)Study completedNCT01176409
What this trial is testing

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?

Who this might be right for
Human Immunodeficiency VirusHerpes Simplex
University Health Network, Toronto 60
Not applicableStudy completedNCT00006298
What this trial is testing

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 125
Testing effectiveness (Phase 2)Ended earlyNCT03669133
What this trial is testing

Vitamin E for NASH Treatment in HIV Infected Individuals

Who this might be right for
NAFLDNASH - Nonalcoholic SteatohepatitisHIV Infections
Indiana University 3
Testing effectiveness (Phase 2)Temporarily pausedNCT05525156
What this trial is testing

The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy

Who this might be right for
HivCardiovascular Diseases
Muhimbili University of Health and Allied Sciences 454
Early research (Phase 1)Active Not RecruitingNCT04248192
What this trial is testing

Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)

Who this might be right for
HIV-Infected Individuals
Catherine Bollard 8
Large-scale testing (Phase 3)Study completedNCT01516060
What this trial is testing

The Neurocognitive Sub-study of Encore1

Who this might be right for
HIV
Kirby Institute 71
Large-scale testing (Phase 3)Study completedNCT01271894
What this trial is testing

The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

Who this might be right for
HIV Infection
Kirby Institute 40
Not applicableStudy completedNCT00001089
What this trial is testing

HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07797894
What this trial is testing

Safety and Immunogenicity of HPV Vaccine in HIV-infected

Who this might be right for
HIV-infected Individuals
Beijing 302 Hospital 80
Not applicableStudy completedNCT00000859
What this trial is testing

Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,300
Not applicableStudy completedNCT06730867
What this trial is testing

Piloting Eye Movement Desensitization and Reprocessing (EMDR) Therapy in People Living With HIV and Trauma

Who this might be right for
HIV Infected Individuals
Vanderbilt University Medical Center 14
Not applicableStudy completedNCT00373048
What this trial is testing

Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

Who this might be right for
HIV Infections
Institute of Tropical Medicine, Belgium 300
Very early researchStudy completedNCT01836068
What this trial is testing

Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals

Who this might be right for
HIV
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Testing effectiveness (Phase 2)Study completedNCT00272493
What this trial is testing

Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Next Page